Stock SUVEN SUVEN LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Suven Life Sciences Limited NSE India S.E.

Equities

SUVEN

INE495B01038

Delayed NSE India S.E.
Other stock markets
 01:31:40 2024-04-26 am EDT 		5-day change 1st Jan Change
111.9 INR -1.50% Intraday chart for Suven Life Sciences Limited +5.23% +38.33%
Apr. 15 Suven Life Sciences to Present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology 2024 Annual Meeting, Denver, USA CI
Feb. 06 Suven Life Sciences Announces Randomization of First Patient in Phase-2 POC Clinical Trial of Ropanicant (SUVN-911) for the Treatment of Moderate to Severe Major Depressive Disorder Study in USA CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. SUVEN Stock
  4. SUVEN Stock
  5. News Suven Life Sciences Limited
  6. Official Publications